Oral postinflammatory pigmentation: an analysis of 7 cases.

Med Oral Patol Oral Cir Bucal

Department of Otolaryngological/Dental/Ophthalmological and Cervico-Facial Sciences, University of Parma, Italy.

Published: January 2011

Oral postinflammatory pigmentation (OPP) is a discoloration of the oral mucosa caused by an excess of melanin production and deposition within the basal layer of the epithelium and connective tissue of areas affected by chronic inflammation. Therefore, it is mandatory to demonstrate the association with a previous or concomitant inflammatory process in the same area of oral mucosa. Clinically OPP appears as a localized or diffuse, black to brown pigmentation. OPP may persist for many years even though the disappearing of the pigmentation after the resolution of the inflammatory state has been reported. We reviewed retrospectively the medical records and, when performed, biopsy examinations of 7 cases of OPP. Four cases were associated with oral lichen planus, two cases with lichenoid lesions and one case with proliferative verrucous leukoplakia. Despite a possible high prevalence of OPP, only a few reports concerning diagnosis, etiopathogenesis and clinical manifestation have been published so far.

Download full-text PDF

Source
http://dx.doi.org/10.4317/medoral.16.e11DOI Listing

Publication Analysis

Top Keywords

oral postinflammatory
8
postinflammatory pigmentation
8
pigmentation opp
8
oral mucosa
8
oral
5
opp
5
pigmentation
4
pigmentation analysis
4
cases
4
analysis cases
4

Similar Publications

Introduction: Acne is a one of the most frequent skin conditions among teenagers and young adults. It is currently managed with topical retinoids and antibiotics, which can present numerous side effects, thus reducing treatment adherence and effectiveness. We evaluated the efficacy and tolerability of a novel dermo-cosmetic cream (α-AZ) in treating mild to moderate acne.

View Article and Find Full Text PDF

Tranexamic Acid for the Treatment of Hyperpigmentation and Telangiectatic Disorders Other Than Melasma: An Update.

Clin Cosmet Investig Dermatol

September 2024

The Institute of Dermatology and Venereology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.

Article Synopsis
  • - Tranexamic acid (TXA) is primarily an antifibrinolytic agent used to control bleeding in trauma and surgeries, and it also helps prevent bleeding in hemophilia patients.
  • - Recent studies suggest TXA has additional benefits like reducing pigmentation, inflammation, and promoting skin recovery, leading to its exploration as a treatment for various skin issues.
  • - The review focuses on TXA's effectiveness for conditions like post-inflammatory hyperpigmentation and rosacea, advocating for its potential use beyond melasma as a safer, cost-effective treatment option.
View Article and Find Full Text PDF

Oral Tranexamic Acid for Prevention and Treatment of Postinflammatory Hyperpigmentation.

Dermatol Surg

December 2024

Pediatric and Cosmetic Dermatologist, Northwell Health, NY.

Article Synopsis
  • Postinflammatory hyperpigmentation (PIH) is a skin disorder caused by inflammation and damage, leading to excessive pigment in the skin.
  • Oral tranexamic acid (TXA), mainly used to stop bleeding, shows promise in treating PIH and has been studied for its efficacy and safety.
  • Research indicates that TXA significantly improves PIH and can be effective when combined with other treatments, making it a viable option for patients.
View Article and Find Full Text PDF

Retrospective Analysis of the Effectiveness of Laser Therapy in the Treatment of Acne Scarring.

J Pharm Bioallied Sci

July 2024

Senior Consultant, Oral and Maxillofacial Surgeon, Clove Dental, Visakhapatnam, Andhra Pradesh, India.

Objective: This retrospective analysis aimed to estimate the efficiency of laser therapy in the management of acne scarring, assessing changes in scar severity, patient satisfaction, and adverse events.

Methods: A cohort of 150 subjects with clinically diagnosed acne scarring who underwent laser therapy. Data were extracted from electronic medical records, and baseline characteristics, scar types, and management parameters were analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • * A skin biopsy showed mild spongiosis and inflammation, confirming the diagnosis of PP.
  • * Treatment involved stopping the ketogenic diet and using oral doxycycline, which cleared the lesions within a month, although some post-inflammatory hyperpigmentation remained.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!